Additional file 2: of EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

Semmlinger, Anna; von Schoenfeldt, Viktoria; Wolf, Verena; Meuter, Alexandra; Kolben, Theresa; Kolben, Thomas; Zeder-Goess, Christine; Weis, Florian; Gallwas, Julia; Wuerstlein, Rachel; Hermelink, Kerstin; Schmoeckel, Elisa; Harbeck, Nadia; Mayr, Doris; Mahner, Sven; Jeschke, Udo; Ditsch, Nina

doi:10.6084/m9.figshare.6147182.v1

12885_2018_4286_MOESM2_ESM.pdf (20.99 kB)

Additional file 2: of EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

journal contribution

posted on 2018-04-16, 05:00 authored by Anna Semmlinger, Viktoria von Schoenfeldt, Verena Wolf, Alexandra Meuter, Theresa Kolben, Thomas Kolben, Christine Zeder-Goess, Florian Weis, Julia Gallwas, Rachel Wuerstlein, Kerstin Hermelink, Elisa Schmoeckel, Nadia Harbeck, Doris Mayr, Sven Mahner, Udo Jeschke, Nina Ditsch

Figure S2. Schoenfeld residuals for EP3. To test for PH assumption, Schoenfeld residual test was performed for EP3 for OS and PFS. Schoenfeld residuals for EP3 are displayed (left: OS, right: PFS). There is no violation of PH assumption, as the ratio of both curves is stable over the time. (PDF 20 kb)

Funding

Medical Faculty of the LMU Munich

History

Usage metrics

Keywords

Breast cancer EP3 Prostaglandin E2 EP-receptor COX-2 PGE2 Prognostic factor

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: of EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

Funding

Medical Faculty of the LMU Munich

History

Usage metrics

Categories

Keywords

Licence

Exports